10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 183,979 | 153,644 | 146,819 | 134,285 | 156,232 |
| Cost of Goods | 68,197 | 58,115 | 47,207 | 35,895 | 36,827 |
| Gross Profit | 115,782 | 95,529 | 99,612 | 98,390 | 119,405 |
| Operating Expenses | 171,167 | 190,439 | 163,177 | 151,273 | 143,328 |
| Operating Income | -55,188 | -94,795 | -63,358 | -51,988 | -23,096 |
| Interest Expense | 8 | 1 | 5 | 19 | 125 |
| Other Income | 8,598 | 3,052 | 2,596 | 2,353 | 6,810 |
| Pre-tax Income | -46,598 | -91,744 | -60,767 | -49,654 | -16,411 |
| Income Tax | 2,354 | 1,242 | 1,647 | 1,093 | 804 |
| Net Income Continuous | -48,952 | -92,986 | -62,414 | -50,747 | -17,215 |
| Net Income | $-48,952 | $-92,986 | $-62,414 | $-50,747 | $-17,215 |
| EPS Basic Total Ops | -0.42 | -0.79 | -0.53 | -0.44 | -0.14 |
| EPS Basic Continuous Ops | -0.41 | -0.79 | -0.53 | -0.44 | -0.15 |
| EPS Diluted Total Ops | -0.42 | -0.79 | -0.53 | -0.44 | -0.14 |
| EPS Diluted Continuous Ops | -0.41 | -0.79 | -0.53 | -0.44 | -0.15 |
| EBITDA(a) | $-43,482 | $-83,375 | $-51,481 | $-43,372 | $-14,624 |